21/11/2024 13:41
Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd p OriginalResearch: Pentixapharm Holding AG von BankM AG br/br/ 21.11.2024 / 13:40 CET/CESTbr/ Veröffentlichung einer Research, übermittelt durch EQS News ein Service der EQS Group AG.br/ Für den Inhalt der... Lire...
21/11/2024 11:00
EQS-News: First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Study br/ First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177PentixaTher, Expanding the... Lire...
12/11/2024 17:45
EQS-News: Pentixapharm Releases Interim Report for the Third Quarter of 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Quarterly / Interim Statement br/ Pentixapharm Releases Interim Report for the Third Quarter of 2024 br/br/ 12.11.2024 / 17:45... Lire...
04/11/2024 17:26
EQS-News: Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Statement br/ Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals br/br/ 04.11.2024 /... Lire...
29/10/2024 11:46
EQS-News: Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Study br/ Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor br/br/ 29.10.2024 /... Lire...
28/10/2024 12:26
EQS-News: Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Personnel br/ Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG br/br/ 28.10.2024 / 12:26... Lire...
25/10/2024 16:00
EQS-News: Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Personnel br/ Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group... Lire...
19/10/2024 12:28
EQS-News: Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM)
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Conference br/ Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear... Lire...
18/10/2024 15:49
EQS-Adhoc: EMA Grants PRIME Status to Pentixapharm’s Lead Candidate PentixaFor
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Pentixapharm Holding AG / Key words: Studybr/ EMA Grants PRIME Status to Pentixapharm’s Lead Candidate PentixaFor br/br/ 18Oct2024 / 15:49 CET/CESTbr/ Disclosure of an inside information acc. to... Lire...